Ranking results:

Past rankings:

2012
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000
Networking Rank (Reputation):	> 1000
2008
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2013	0	11.959.743	2.244.340		2
2012	0	5.512.424	551.242		1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
UNIVERSITY OF NEWCASTLE UPON TYNE	3
CONSULTANTS FOR RESEARCH IN IMAGING AND SPECTROSCOPY SCRL	2
LEIDEN UNIVERSITY MEDICAL CENTER	2
PROSENSA THERAPEUTICS BV	2
UNIVERSITA CATTOLICA DEL SACRO CUORE	2
UNIVERSITY COLLEGE LONDON	2
BIOSPRING	1
CHARLES RIVER LABORATORIES PRECLINICAL SERVICES EDINBURGH	1
GREAT ORMOND STREET HOSPITAL FOR CHILDREN NHS TRUST	1
KATHOLIEKE UNIVERSITEIT LEUVEN	1
ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE	1
SAREPTA THERAPEUTICS INC CORPORATION	1
SCITO S A	1
SYSNAV SAS	1

Constancy:

Total number of partners: 21
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 18
Frequent / Rare Partner Ratio: 0.17

Project overview:

Start date	Project	acronym	role	funding	partners
2013-10-01	BIOIMAGE-Neuromuscular Diseases	BIOIMAGE-NMD	participant	5.960.533	9
2013-06-01	Consortium for Products across Europe in Duchenne Muscular Dystrophy	SCOPE-DMD	participant	5.999.210	5
2012-11-01	A phase I/IIa clinical trial in Duchenne muscular dystrophy using systemically delivered morpholino antisense oligomer to skip exon 53	SKIP-NMD	participant	5.512.424	10

Alias institution names:

ASSOCIATION INSTITUT DE MYOLOGIE

ASSOCIATION INSTITUT DE MYOLOGIE - France